COMPANY PROFILE

Alveo Technologies

Explore full profile

Pre-clinical stage medical diagnostics company

Alameda, United StatesFounded 2014Biotech & Life Sciences

Valuation $100–250M Last recorded · 2018

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Alveo Technologies

Alveo Technologies specializes in molecular detection platforms designed for early and actionable pathogen detection, aiming to secure global health and prevent future pandemics. The company operates in the healthcare, agriculture, and environmental sectors, serving clients ranging from healthcare providers to agricultural businesses. Alveo's business model revolves around providing handheld diagnostic tools that bring molecular detection out of the lab and into the field, making early pathogen detection accessible at the point of need. Revenue is generated through the sale of these diagnostic devices and partnerships for co-developing assays on their open platform. Alveo's commitment to equitable access to accurate diagnostics drives its mission to positively impact communities worldwide.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2014
Headquarters: Alameda, United States
Employees: 66
Open positions: 2
Dealroom signal: 73.5/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VCOther financing	Mar 2021	$16M	$64M	Undisclosed	—
SERIES AOther financing	Jan 2018	$38M	$152M	Maxim Group LLC	—

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Alveo Technologies website traffic

Latest recorded traffic for Alveo Technologies is 3.2K monthly website visits, up 45.5% over the last three months. Alveo Technologies's team declined 4.3% over the past year.

Latest monthly visits3.2K 3-month web change+45.5% 1-year team growth-4.3%

Monthly website visitsOct 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
XBxCystence BioTherapeutics for Polycystic Kidney Disease treatment	District of Tuggeranong, Australia	Operational	3	$485K	—
AVAviadoBioPrecision gene therapies for neurodegenerative disorders	London, United Kingdom	Operational
TTTay TherapeuticsBiotech platform enhancing patient-specific medicines through advanced discovery and development expertise	Dundee, United Kingdom	Operational
AIAiberRemote medical support technology for aviation and maritime	Winshill, United Kingdom	Operational
EHEdifice HealthOffers inflammatory health monitoring tests to help manage chronic inflammation and improve overall health and longevity	San Mateo, United States	Operational
NENeomorphDeveloping novel drugs targeting previously untreatable disease-causing proteins using molecular degradation technology	San Diego, United States	Operational
CTCV6 TherapeuticsCombination therapies enhancing cornerstone cancer and inflammatory treatments	Belfast, United Kingdom	Operational
GEGelmetixInjectable polymer gel for non-surgical chronic pain treatment	London, United Kingdom	Operational